Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/BIOCORRX-INC-111313930/nieuws/BioCorRx-krijgt-IRB-goedkeuring-om-Fase-I-klinische-proef-te-beginnen-met-BICX104-een-implanteerbar-39791626/?utm_source=whatsapp&utm_medium=social&utm_campaign=share